RNAiドラッグデリバリー市場は、2022年から2027年の間に1,097億3,000万米ドル成長し、予測期間中に20.83 %のCAGRで加速すると予測されています。RNAiドラッグデリバリー市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題に加えて、約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場を牽引しているのは、RNAi治療薬の高い標的親和性と特異性、製薬・バイオテクノロジー分野における研究活動の活発化、神経疾患の有病率の増加です。
本調査では、今後数年間のRNAiドラッグデリバリー市場の成長を促進する主な理由の一つとして、ベンダーによるRNAi治療の研究開発の増加を挙げています。また、複数の治療分野におけるRNAi治療薬への注目の高まりや、RNAiアプローチにおける科学的進歩も、市場の大きな需要につながるでしょう。
堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、RNAiドラッグデリバリー市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global RNAi drug delivery market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global rnai drug delivery market 2017 - 2021 ($ billion)
4.2 Technology Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Technology Segment 2017 - 2021 ($ billion)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Technology
6.1 Market segments
Exhibit 30: Chart on Technology - Market share 2022-2027 (%)
Exhibit 31: Data Table on Technology - Market share 2022-2027 (%)
6.2 Comparison by Technology
Exhibit 32: Chart on Comparison by Technology
Exhibit 33: Data Table on Comparison by Technology
6.3 Nanoparticle drug delivery - Market size and forecast 2022-2027
Exhibit 34: Chart on Nanoparticle drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Nanoparticle drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Nanoparticle drug delivery - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Nanoparticle drug delivery - Year-over-year growth 2022-2027 (%)
6.4 Pulmonary drug delivery - Market size and forecast 2022-2027
Exhibit 38: Chart on Pulmonary drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Pulmonary drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Pulmonary drug delivery - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Pulmonary drug delivery - Year-over-year growth 2022-2027 (%)
6.5 Nucleic acid drug delivery - Market size and forecast 2022-2027
Exhibit 42: Chart on Nucleic acid drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Nucleic acid drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Nucleic acid drug delivery - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Nucleic acid drug delivery - Year-over-year growth 2022-2027 (%)
6.6 Aptamer drug delivery - Market size and forecast 2022-2027
Exhibit 46: Chart on Aptamer drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Aptamer drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Aptamer drug delivery - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Aptamer drug delivery - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Technology
Exhibit 50: Market opportunity by Technology ($ billion)
Exhibit 51: Data Table on Market opportunity by Technology ($ billion)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 52: Chart on Application - Market share 2022-2027 (%)
Exhibit 53: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 54: Chart on Comparison by Application
Exhibit 55: Data Table on Comparison by Application
7.3 Infectious diseases - Market size and forecast 2022-2027
Exhibit 56: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibit 58: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
7.4 Oncology - Market size and forecast 2022-2027
Exhibit 60: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
7.5 Cardiology - Market size and forecast 2022-2027
Exhibit 64: Chart on Cardiology - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Cardiology - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
7.6 Neurology - Market size and forecast 2022-2027
Exhibit 68: Chart on Neurology - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on Neurology - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
7.7 Others - Market size and forecast 2022-2027
Exhibit 72: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 75: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Application
Exhibit 76: Market opportunity by Application ($ billion)
Exhibit 77: Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 81: Chart on Geographic comparison
Exhibit 82: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 115: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 116: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 117: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 121: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 123: Overview on factors of disruption
11.4 Industry risks
Exhibit 124: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 125: Vendors covered
12.2 Market positioning of vendors
Exhibit 126: Matrix on vendor position and classification
12.3 Alnylam Pharmaceuticals Inc.
Exhibit 127: Alnylam Pharmaceuticals Inc. - Overview
Exhibit 128: Alnylam Pharmaceuticals Inc. - Product / Service
Exhibit 129: Alnylam Pharmaceuticals Inc. - Key news
Exhibit 130: Alnylam Pharmaceuticals Inc. - Key offerings
12.4 Arbutus Biopharma Corp.
Exhibit 131: Arbutus Biopharma Corp. - Overview
Exhibit 132: Arbutus Biopharma Corp. - Product / Service
Exhibit 133: Arbutus Biopharma Corp. - Key offerings
12.5 Arrowhead Pharmaceuticals Inc.
Exhibit 134: Arrowhead Pharmaceuticals Inc. - Overview
Exhibit 135: Arrowhead Pharmaceuticals Inc. - Business segments
Exhibit 136: Arrowhead Pharmaceuticals Inc. - Key offerings
Exhibit 137: Arrowhead Pharmaceuticals Inc. - Segment focus
12.6 Bayer AG
Exhibit 138: Bayer AG - Overview
Exhibit 139: Bayer AG - Business segments
Exhibit 140: Bayer AG - Key news
Exhibit 141: Bayer AG - Key offerings
Exhibit 142: Bayer AG - Segment focus
12.7 BioNTech SE
Exhibit 143: BioNTech SE - Overview
Exhibit 144: BioNTech SE - Product / Service
Exhibit 145: BioNTech SE - Key offerings
12.8 Bristol Myers Squibb Co.
Exhibit 146: Bristol Myers Squibb Co. - Overview
Exhibit 147: Bristol Myers Squibb Co. - Product / Service
Exhibit 148: Bristol Myers Squibb Co. - Key news
Exhibit 149: Bristol Myers Squibb Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Novartis AG
Exhibit 155: Novartis AG - Overview
Exhibit 156: Novartis AG - Business segments
Exhibit 157: Novartis AG - Key offerings
Exhibit 158: Novartis AG - Segment focus
12.11 Novo Nordisk AS
Exhibit 159: Novo Nordisk AS - Overview
Exhibit 160: Novo Nordisk AS - Business segments
Exhibit 161: Novo Nordisk AS - Key offerings
Exhibit 162: Novo Nordisk AS - Segment focus
12.12 Phio Pharmaceuticals
Exhibit 163: Phio Pharmaceuticals - Overview
Exhibit 164: Phio Pharmaceuticals - Product / Service
Exhibit 165: Phio Pharmaceuticals - Key offerings
12.13 Sanofi
Exhibit 166: Sanofi - Overview
Exhibit 167: Sanofi - Business segments
Exhibit 168: Sanofi - Key news
Exhibit 169: Sanofi - Key offerings
Exhibit 170: Sanofi - Segment focus
12.14 Silence Therapeutics plc
Exhibit 171: Silence Therapeutics plc - Overview
Exhibit 172: Silence Therapeutics plc - Product / Service
Exhibit 173: Silence Therapeutics plc - Key offerings
12.15 Sirnaomics Inc.
Exhibit 174: Sirnaomics Inc. - Overview
Exhibit 175: Sirnaomics Inc. - Product / Service
Exhibit 176: Sirnaomics Inc. - Key offerings
12.16 Sylentis S.A.
Exhibit 177: Sylentis S.A. - Overview
Exhibit 178: Sylentis S.A. - Product / Service
Exhibit 179: Sylentis S.A. - Key offerings
12.17 Thermo Fisher Scientific Inc.
Exhibit 180: Thermo Fisher Scientific Inc. - Overview
Exhibit 181: Thermo Fisher Scientific Inc. - Business segments
Exhibit 182: Thermo Fisher Scientific Inc. - Key news
Exhibit 183: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 184: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 185: Inclusions checklist
Exhibit 186: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 187: Currency conversion rates for US$
13.4 Research methodology
Exhibit 188: Research methodology
Exhibit 189: Validation techniques employed for market sizing
Exhibit 190: Information sources
13.5 List of abbreviations
Exhibit 191: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global rnai drug delivery market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Technology Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Technology - Market share 2022-2027 (%)
Exhibits31: Data Table on Technology - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Technology
Exhibits33: Data Table on Comparison by Technology
Exhibits34: Chart on Nanoparticle drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Nanoparticle drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Nanoparticle drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Nanoparticle drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Pulmonary drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Pulmonary drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Pulmonary drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Pulmonary drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Nucleic acid drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Nucleic acid drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Nucleic acid drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Nucleic acid drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Aptamer drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Aptamer drug delivery - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Aptamer drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Aptamer drug delivery - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Technology ($ billion)
Exhibits51: Data Table on Market opportunity by Technology ($ billion)
Exhibits52: Chart on Application - Market share 2022-2027 (%)
Exhibits53: Data Table on Application - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by Application
Exhibits55: Data Table on Comparison by Application
Exhibits56: Chart on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Infectious diseases - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Infectious diseases - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Cardiology - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Cardiology - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Cardiology - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Neurology - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Neurology - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits76: Market opportunity by Application ($ billion)
Exhibits77: Data Table on Market opportunity by Application ($ billion)
Exhibits78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits81: Chart on Geographic comparison
Exhibits82: Data Table on Geographic comparison
Exhibits83: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits116: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits117: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits119: Market opportunity By Geographical Landscape ($ billion)
Exhibits120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits121: Impact of drivers and challenges in 2022 and 2027
Exhibits122: Overview on Criticality of inputs and Factors of differentiation
Exhibits123: Overview on factors of disruption
Exhibits124: Impact of key risks on business
Exhibits125: Vendors covered
Exhibits126: Matrix on vendor position and classification
Exhibits127: Alnylam Pharmaceuticals Inc. - Overview
Exhibits128: Alnylam Pharmaceuticals Inc. - Product / Service
Exhibits129: Alnylam Pharmaceuticals Inc. - Key news
Exhibits130: Alnylam Pharmaceuticals Inc. - Key offerings
Exhibits131: Arbutus Biopharma Corp. - Overview
Exhibits132: Arbutus Biopharma Corp. - Product / Service
Exhibits133: Arbutus Biopharma Corp. - Key offerings
Exhibits134: Arrowhead Pharmaceuticals Inc. - Overview
Exhibits135: Arrowhead Pharmaceuticals Inc. - Business segments
Exhibits136: Arrowhead Pharmaceuticals Inc. - Key offerings
Exhibits137: Arrowhead Pharmaceuticals Inc. - Segment focus
Exhibits138: Bayer AG - Overview
Exhibits139: Bayer AG - Business segments
Exhibits140: Bayer AG - Key news
Exhibits141: Bayer AG - Key offerings
Exhibits142: Bayer AG - Segment focus
Exhibits143: BioNTech SE - Overview
Exhibits144: BioNTech SE - Product / Service
Exhibits145: BioNTech SE - Key offerings
Exhibits146: Bristol Myers Squibb Co. - Overview
Exhibits147: Bristol Myers Squibb Co. - Product / Service
Exhibits148: Bristol Myers Squibb Co. - Key news
Exhibits149: Bristol Myers Squibb Co. - Key offerings
Exhibits150: F. Hoffmann La Roche Ltd. - Overview
Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
Exhibits152: F. Hoffmann La Roche Ltd. - Key news
Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits155: Novartis AG - Overview
Exhibits156: Novartis AG - Business segments
Exhibits157: Novartis AG - Key offerings
Exhibits158: Novartis AG - Segment focus
Exhibits159: Novo Nordisk AS - Overview
Exhibits160: Novo Nordisk AS - Business segments
Exhibits161: Novo Nordisk AS - Key offerings
Exhibits162: Novo Nordisk AS - Segment focus
Exhibits163: Phio Pharmaceuticals - Overview
Exhibits164: Phio Pharmaceuticals - Product / Service
Exhibits165: Phio Pharmaceuticals - Key offerings
Exhibits166: Sanofi - Overview
Exhibits167: Sanofi - Business segments
Exhibits168: Sanofi - Key news
Exhibits169: Sanofi - Key offerings
Exhibits170: Sanofi - Segment focus
Exhibits171: Silence Therapeutics plc - Overview
Exhibits172: Silence Therapeutics plc - Product / Service
Exhibits173: Silence Therapeutics plc - Key offerings
Exhibits174: Sirnaomics Inc. - Overview
Exhibits175: Sirnaomics Inc. - Product / Service
Exhibits176: Sirnaomics Inc. - Key offerings
Exhibits177: Sylentis S.A. - Overview
Exhibits178: Sylentis S.A. - Product / Service
Exhibits179: Sylentis S.A. - Key offerings
Exhibits180: Thermo Fisher Scientific Inc. - Overview
Exhibits181: Thermo Fisher Scientific Inc. - Business segments
Exhibits182: Thermo Fisher Scientific Inc. - Key news
Exhibits183: Thermo Fisher Scientific Inc. - Key offerings
Exhibits184: Thermo Fisher Scientific Inc. - Segment focus
Exhibits185: Inclusions checklist
Exhibits186: Exclusions checklist
Exhibits187: Currency conversion rates for US$
Exhibits188: Research methodology
Exhibits189: Validation techniques employed for market sizing
Exhibits190: Information sources
Exhibits191: List of abbreviations
